PTEN and prostate carcinoma: Our earlier study concluded that loss of Pten and TP53, two common genetic lesions in prostate cancer, promotes the EMT and cell plasticity in a mouse prostate-specific Pten/Trp53 double-knockout mouse model [24, 26].